Kovai Medical Center & Hospital Ltd

₹ 1,763 0.13%
02 Dec - close price
About

Kovai Medical Center & Hospital Ltd is a Coimbatore-based company which is in the business of advanced healthcare services. It also forayed into education services in 2019 with the commencement of its new Medical College in Coimbatore.[1]

Key Points

Hospital Portfolio
The company owns 1 multi-speciality medical centre along with 5 other small-medium scale hospitals in Coimbatore and Erode in Tamil Nadu.[1]
It has a capacity of ~1,400 beds through its hospitals.[2]

  • Market Cap 1,929 Cr.
  • Current Price 1,763
  • High / Low 1,925 / 1,299
  • Stock P/E 19.5
  • Book Value 600
  • Dividend Yield 0.17 %
  • ROCE 16.4 %
  • ROE 18.8 %
  • Face Value 10.0

Pros

Cons

  • Stock is trading at 2.94 times its book value
  • The company has delivered a poor sales growth of 11.3% over past five years.
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
177 192 178 129 184 179 199 239 218 229 221 236 252
135 141 137 106 123 127 141 164 154 165 166 174 184
Operating Profit 41 51 40 22 61 52 58 75 64 64 55 62 68
OPM % 23% 26% 23% 17% 33% 29% 29% 31% 29% 28% 25% 26% 27%
2 3 3 3 2 2 5 2 2 4 3 4 3
Interest 4 3 4 7 8 8 9 11 11 11 10 10 10
Depreciation 10 11 22 16 17 17 18 19 23 22 21 23 22
Profit before tax 29 39 17 2 38 29 36 47 32 36 26 32 39
Tax % 44% 37% -94% 27% 25% 30% 26% 25% 25% 27% 28% 27% 23%
Net Profit 16 25 33 2 29 21 27 35 24 26 19 24 30
EPS in Rs 14.95 22.75 30.61 1.41 26.07 18.96 24.55 32.19 22.07 23.82 17.20 21.74 27.67
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
175 222 297 334 402 465 531 588 628 712 690 906 938
139 179 227 261 307 374 406 459 494 540 495 645 689
Operating Profit 36 43 70 73 94 92 125 129 135 171 195 261 249
OPM % 21% 20% 24% 22% 23% 20% 23% 22% 21% 24% 28% 29% 27%
1 2 3 5 7 8 6 7 8 10 12 11 14
Interest 11 17 27 24 20 17 15 13 15 18 33 46 41
Depreciation 7 12 15 16 21 21 24 34 36 52 68 85 88
Profit before tax 20 16 31 37 59 62 92 89 93 112 106 141 133
Tax % 38% 26% 32% 36% 35% 35% 35% 35% 35% 15% 27% 26%
Net Profit 12 12 21 24 39 40 60 58 60 95 78 104 99
EPS in Rs 11.05 10.92 19.42 21.68 35.37 36.95 54.81 52.99 54.96 86.44 71.00 95.28 90.43
Dividend Payout % 11% 11% 8% 7% 4% 7% 5% 6% 5% 3% 4% 6%
Compounded Sales Growth
10 Years: 15%
5 Years: 11%
3 Years: 13%
TTM: 12%
Compounded Profit Growth
10 Years: 24%
5 Years: 12%
3 Years: 20%
TTM: -8%
Stock Price CAGR
10 Years: 26%
5 Years: 6%
3 Years: 32%
1 Year: 7%
Return on Equity
10 Years: 22%
5 Years: 20%
3 Years: 20%
Last Year: 19%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Sep 2022
11 11 11 11 11 11 11 11 11 11 11 11 11
Reserves 40 50 70 91 127 165 224 276 332 420 499 598 646
192 228 209 184 163 158 125 202 378 543 623 550 534
41 50 55 65 85 96 103 116 129 134 148 184 189
Total Liabilities 284 339 345 351 386 430 464 605 850 1,108 1,281 1,343 1,379
185 288 279 277 281 337 354 443 469 643 1,033 1,085 1,055
CWIP 38 0 5 5 17 10 6 13 227 300 45 5 9
Investments 4 4 4 4 4 4 4 0 0 0 0 0 0
57 46 57 65 85 78 100 149 153 165 203 253 315
Total Assets 284 339 345 351 386 430 464 605 850 1,108 1,281 1,343 1,379

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
41 56 62 68 97 85 99 87 126 152 186 263
-97 -77 -9 -12 -80 -113 -83 -192 -352 -335 -180 -99
71 17 -48 -52 -43 -24 -50 60 160 113 38 -120
Net Cash Flow 15 -4 6 4 -26 -53 -33 -45 -66 -70 44 44

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 14 5 5 8 9 7 8 8 6 4 7 8
Inventory Days 37 36 35 33 25 22 20 23 20 23 19 19
Days Payable 25 32 29 35 53 47 37 43 47 46 29 20
Cash Conversion Cycle 26 9 11 6 -19 -19 -9 -12 -21 -19 -2 6
Working Capital Days -51 -60 -49 -43 -56 -52 -47 -48 -49 -36 -38 -37
ROCE % 16% 12% 20% 21% 27% 25% 31% 24% 18% 15% 13% 16%

Shareholding Pattern

Numbers in percentages

Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
50.81 50.80 50.80 50.80 50.80 55.76 55.76 55.74 55.74 55.71 55.76 55.76
3.69 3.05 2.93 2.76 2.57 2.57 2.08 2.08 2.09 2.13 2.12 2.14
1.01 1.01 1.01 1.39 1.54 0.98 1.43 1.72 1.77 1.95 1.95 1.92
44.49 45.14 45.26 45.05 45.09 40.69 40.73 40.46 40.40 40.21 40.17 40.19

* The XBRL reporting format changed from Sep'2022 onwards. The new format added details about banks and foreign portfolio investors. These were not available earlier.
The sudden increase in FII or DII might be because of these changes.

Please click on the line-items to see the names of individual entities.

Documents